Does surgical smoke spread bladder cancer during RARC? New research finds no cancer cells or DNA present. Learn more about ...

Deion Sanders has always been as electrifying off the field as he was on it, but recent spring practice footage has sparked ...

Radical cystectomy, or complete bladder removal, remains the standard and most effective surgery for muscle‑invasive bladder ...

As a potential biomarker of treatment response, ctDNA and utDNA analyses were performed before systemic therapy, at restaging, and for responders at the beginning of adjuvant nivolumab. ctDNA was ...

A growing body of research seeks to validate ctDNA as a means of guiding MIBC treatment, particularly immunotherapy.

Chief Executive Officer Ron Cooper used a presentation at the Citizens Life Sciences Conference to outline the company’s ...

Bleeding during urologic surgery can lead to transfusions and major complications. The POISE-3 tested prophylaxis in at-risk ...

Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2025 Earnings Call Transcript March 19, 2026 Relmada Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.27 EPS, expectations were ...

Shenouda With me on today's call are Relmada Therapeutics, Inc.'s CEO, Dr. Sergio Traversa, who will briefly provide a summary of recent business highlights; Dr. Raj S. Pruthi, Relmada Therapeutics, ...

Positive 12-month Phase 2 data for NDV-01 in non-muscle invasive bladder cancer (NMIBC) demonstrated a 95% complete response (CR) rate at any time and a durable 76% CR rate at 12 months, with ...

A female patient in her 60s with bipolar disorder type 1 underwent robot-assisted radical cystectomy with ileal conduit for muscle-invasive bladder cancer. Postoperatively, she continued her regular ...

Oncology Media Relations   [email protected]     Investor contact: Jess Margevich [email protected] ...